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Summary
Introduction: cell-based tissue engineering strate-
gies using human mesenchymal stem cells (hM-
SCs) may help to augment tendon healing. To fur-
ther investigate the in-vitro behavior of this cell
population, we investigated low oxygen culture
levels, and growth factor supplementation and
their effect on expression of tendon extracellular
proteins and cell proliferation.
Materials and methods: bone marrow aspirate
(BMA) was harvested during arthroscopic rotator
cuff repair. Characterized hMSCs derived from
BMA were incorporated into 3-dimensional tissue
engineered constructs (TECs). TECs were ana-
lyzed by frozen sections with immunohistochem-
istry for cell density, collagen I and collagen III
expression.
Results: growth factor stimulation and low oxy-
gen increased cell density within TECs. Low oxy-
gen and addition of growth factors to culture me-
dia demonstrated an increase in collagen I and III
expression, both in ambient oxygen conditions
and low oxygen conditions. 
Conclusion: low oxygen and TGFβ3 demonstrat-
ed a positive effect on cell number, and type I
and III collagen expression in 3D culture environ-
ments.
KEY WORDS: construct, low oxygen, mesenchymal stem
cells, tendon, transforming growth factor beta.
Introduction
Tendon injury is commonly encountered in the or-
thopaedic clinic, and is estimated to cost the United
States healthcare system approximately 30 billion dol-
lars per year1. Due to an aging population, the preva-
lence of such disease is expected to increase, along
with the number of clinical encounters seen in or-
thopaedic practice2. While surgical management is still
considered gold standard treatment, it consistently
yields variable results, with failure rates ranging from
38-94%3. Failures in tendon repair lead to revision surg-
eries and prolonged courses of physical therapy, lead-
ing to financial strain on the healthcare system, and de-
creased quality of life for the patient4. As a result of
these repeated findings, recent investigation has sought
to develop novel therapies which may involve cell-based
augmentation strategies to improve tendon healing1,5.
While the literature involving tendon physiology has
seen many advancements in recent years, tendon in-
jury and subsequent healing is an issue which re-
mains poorly understood5. Literature investigating the
healing process of tendon has demonstrated that na-
tive cellular and extracellular matrix organization is
lacking after an injury, and thus, the ability to recreate
normal strength and function following surgical repair
is limited6,7. In addition, it is noted in histologic stud-
ies of injured tendon, that misaligned type III collagen
predominates the majority of tendon repair tissue,
rather than organized type I collagen found in healthy
embryologically derived tendon8.
Following the observation of varied surgical outcomes,
combined with the understanding that tendon biology
is significantly altered following injury, a body of litera-
ture has emerged, focusing on methods in which the
healing process of tendon may be augmented1,5. Of
the proposed methods, cell based-therapies have re-
mained on the forefront, with human mesenchymal
stem cells (hMSCs) becoming central to this research
having already shown promising results3. Human
MSCs are multipotent cells, which have the ability to
self-renew and differentiate into cell types which in-
clude osteoblasts, tenocytes, chondrocytes and
adipocytes, and with current technology, can be har-
vested from nearly any tissue in the body9-11.
The potential benefit of hMSCs may arise with their di-
rect application to a surgical site, which may serve to
augment the normal physiologic healing response, and
improve surgical outcomes4,12. Such applications have
been investigated in animal models and have shown im-
proved healing rates in anterior cruciate ligament (ACL)
repair, rotator cuff repair (RCR), patellar tendon defects













with cell-based regenerative therapy (CBRT) strategies
using hMSCs may prove useful for treating these com-
plex injuries14. However, further understanding of how
these cells behave in vitro is needed prior to clinical ap-
plication, with emphasis on how to ensure tenogenic dif-
ferentiation of this multipotent progenitor cell type. 
Currently there is paucity in the literature regarding
the response of hMSCs to variables that may be en-
countered when applied in vivo. A growth factor
shown to influence tendon development and healing is
transforming growth factor beta-3 (TGFβ3), which has
demonstrated the ability to increase expression of
tenogenic markers in mesenchymal progenitors in 2-
dimensional cell culture models12,14. Numerous in vitro
studies have shown TGFβ signaling to increase the
expression of tendon collagens, including type I and
III collagen9. In addition, Pryce et al.15 demonstrated a
disruption in TGFβ signaling (TGFβ2 -/-;TGFβ3 -/-) in
double mutant mouse embryos, results in agenesis of
most tendons and ligaments throughout the axial and
appendicular skeleton, indicating that TGFβ signaling
plays a major role in embryonic tenogenesis. 
Oxygen levels of in vitro culture conditions have also
been shown to be a prominent regulator of hMSC lin-
eage tendencies, and thought to be an important in vivo
variable16,17. Partial pressures of oxygen in most in vitro
studies is approximately 140 mmHg, and is thought to
be considerably higher than what is found in most all
mammalian tissues18-20. The partial pressure of oxygen
in arterial blood has been measured from 60-110
mmHg, while that of bone marrow has been measured
in animals and mathematically calculated between 27-
49 mmHg, corresponding with an approximate oxygen
tension of 4-7%19-22. Therefore, it has been conceived
that many cells, including those derived from bone mar-
row aspirate, may behave differently in vitro at oxygen
concentrations lower than the ambient 21%21. A num-
ber of in vitro studies have supported this theory,
demonstrating that low oxygen culture conditions for
hMSCs allows maintenance of their progenitor state,
and appears to regulate their proliferation, viability, and
their commitment to differentiation17,23,24.
The objective of this study was to compare the effect of
growth factor supplementation and cell culture oxygen
levels, on expression of hMSC tendon extracellular ma-
trix proteins, proliferation, and rate of gel construct
compaction in a 3-Dimensional fibrin-based model. The
hypotheses are: (1) TGFβ3 will have a positive net ef-
fect on collagen production, cell proliferation, and rate
of gel compaction and (2) low oxygen culture environ-
ment will have a positive net effect on collagen produc-
tion, cell proliferation, and rate of gel compaction.
Methods
The method described in this paper were considered
best practice in regards to commonly considered
standards for research protocols. Best efforts were
made to make the following justifiable and appropri-
ate for the procurement of the conclusions stated,
and the results from which they were drawn25.
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Experimental design
HMSC-incorporated fibrin gels (1 x 106 cells/ml) were
cultured in ambient (21%) or low (5%) oxygen condi-
tions in cell culture media supplemented with either
10% FBS or 10% FBS +TGFβ3. Tissue engineered
constructs (TECs) were divided into 4 treatment
groups. Normal oxygen with and without TGFβ3 addi-
tion, and low oxygen with and without TGFβ3 addition
(n=3 per group). TGFβ3 was added at a concentra-
tion 10ng/ml to the 10% FBS with each cell media
change, which was done every 3 days.
Isolation of adult hMSCs and expansion in culture
Briefly, we describe the previously published technique
of MSC harvest during arthroscopic rotator cuff repair
(RCR) by Mazzocca et al.3. A 14-gauge aspiration nee-
dle was inserted in the medullary cortex at the bone
cartilage junction of the proximal head of the humerus
where the first suture anchor for the RCR would be
placed, to collect a bone marrow aspirate (BMA). BMA
was centrifuged to isolate the pink middle layer, which
was then aspirated and plated in cell culture dishes in
equal volume distributions. Cells were expanded in ei-
ther ambient (21% O2) or low oxygen (5% O2) condi-
tions, and passaged once prior to creation of TECs.
3D Tissue Engineered Construct (TEC) Creation
HMSCs were incorporated into a fibrin gel at a con-
centration of 1 x 106 cells per ml. 400 μL of cells, 90
μL of fibrinogen and 10 μL of thrombin were mixed to
create a fibrin gel. MSC gels in all groups formed a
uniaxial construct by contracting around two seg-
ments of 0 gauge nylon suture within 6-well plates
(Figs. 1, 2). TECs were grown for a period of 14 days
Figure 1. Drawings depicting lateral and top views (left to
right) of tissue engineered constructs in silicone gel wells,














at 37oC. After 2 weeks, the TECs were harvested for
response measures. 
Immunohistochemistry
TECs were fixed in 10% neutral buffered formalin for
1 hour, frozen in optimal cutting temperature (OCT)
embedding media, and then sectioned in a serial
fashion (7-8 μm) at 3 levels along the construct
height (superficial-middle-deep) to yield 3 levels
which would be averaged together for each technical
replicate. Construct sections were stained with anti-
collagen I (Col1) and anti-collagen III (Col3) antibod-
ies and counterstained with DAPI. 
Image Analysis
Tiled images (10X objective) of the TEC were acquired
and a region of interest was drawn around the gel
perimeter. Each channel was the sholded equally to
create binary images, the positive pixels were counted,
and converted to unit area (mm2), using Fiji image
analysis software25. The staining values were normal-
ized to total TEC area or total cell number to account
for variability in gel compaction and proliferation.
Results 
Raw Type I and III collagen staining
Low oxygen culture and TGFβ3 both demonstrated a
positive effect on type I and III collagen staining rela-
tive to negative control groups both individually and
combined. In addition, it was noted that TGFβ3 addi-
tion in low-oxygen conditions produced a greater in-
crease in type I and III collagen staining relative to
normal oxygen conditions (Fig. 3).
Type I and III Collagen Staining Normalized to Con-
struct Area
Due to variations in size of TEC constructs, type I and
III collagen staining was normalized to the area of the
gel. Low oxygen culture and TGFβ3 both demonstrat-
ed a positive effect on type I and III collagen staining
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Figure 2. Top view of actual tissue engineered construct contracting around suture anchors over time on silicone gel well.
Figure 3. Graph depiction of raw pixel counts of type I and














relative to negative control groups both individually
and combined (Fig. 4).
Type I and III Collagen Staining Normalized to Cell
Number
Due to an appreciable increase in cell number colla-
gen staining was again normalized to cell number to
elucidate extracellular matrix production on a cell-by-
cell basis. Low oxygen culture and TGFβ3 both
demonstrated a positive effect on type I and III colla-
gen staining relative to negative control groups both
individually and combined (Fig. 5). However, in nor-
mal oxygen conditions, TGFβ3 did not produce a net
effect on type III collagen production. 
Discussion 
The purpose of this paper was to investigate the ex-
pression of hMSC extracellular matrix proteins, prolif-
eration, and rate of gel construct compaction in a 3-di-
mensional environment in vitro, in response to ele-
ments that may affect their differentiation in the clini-
cal setting. Variables included low oxygen tension and
TGFβ3 growth factor, as previous studies have shown
these two variables to have significant effects on the
lineage propensities of the hMSC cell type13,27-29.
In this study, we showed that hMSCs are clearly influ-
enced by TGFβ3 and low oxygen culture conditions,
both separately and together. Furthermore, we found
that type I and III collagen extracellular matrix pro-
teins are positively influenced by these variables, in-
dicating that they may be associated with regulation
of hMSC lineage tendencies. 
There is a number of studies to date which have in-
vestigated the nature of TGFβ3 influence on hMSCs.
In the adult, healing tendon has been shown to have
type I and III collagen, however the major constituent
of mature, uninjured tendon is primarily type I colla-
gen30. Kapacee et al.9 performed a study which
demonstrated type I collagen was synthesized in
TECs when in the presence of TGFβ3 growth factor.
Multiple studies investigating TGFβ3 in tendon heal-
ing have shown similar results, implicating TGFβ3
with the formation of mature tendon composed pri-
marily of type I collagen, as opposed to TGFβ1 being
associated with scar-based healing29,31.
Our results parallel findings which suggest TGFβ3
may play a role in the regulation of collagen fibril syn-
thesis, with emphasis on type I collagen13,14,28,29. In
the presence of TGFβ3, we showed an increase in
both type I and III collagen. However, our data further
demonstrated an increase in type I:type III collagen
ratios, indicating type I collagen expression is more
positively influenced than type III collagen in the pres-
ence ofTGFβ3 signaling. This trend was preserved in
the setting of low oxygen culture. 
The effect of TGFβ3 and low oxygen on the type I:III
collagen ratio was of particular interest in this study.
It has been shown in previous biomechanical studies
that mature tendon composed of type I collagen has
higher load-to-failure rates than surgically repaired
tendon composed mainly of scar. As a result, a theo-
retical benefit may be elicited with the application of
hMSCs to a tendon injury site when in the in vivo en-
vironment, as this could aim to promote type I colla-
gen synthesis over scar based healing. 
A number of in vitro studies has investigated the behav-
ior of hMSCs and progenitor cells of their lineage in low
oxygen culture conditions16,24. However, there are no
studies to-date investigating the effect of oxygen levels
on hMSCs and expression of tendon lineage markers,
as the literature currently focuses on bone and carti-
lage, with results remaining inconclusive17,21,32. Lower
oxygen tension with hMSC culture has been shown in a
number of investigations to maintain their progenitor
state, and appears to regulate their proliferation, viabili-
ty, and their commitment to differentiation17,23,24. Malla-
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Figure 4. Graph depiction of pixel counts of type I and III














di et al.17 showed that low oxygen tension diminished
chondrogenesis and osteogenesis in relation to ambi-
ent oxygen conditions.
In our study, low oxygen demonstrated an effect on
hMSCs in a way that parallels previous literature and
played a clear role in the regulation of extracellular
matrix proteins in the 3-dimensional culture environ-
ment. Our data also suggests that synthesis of col-
lagenous proteins is positively influenced in the set-
ting of lower oxygen conditions, relative to ambient
oxygen conditions. In addition, type I collagen synthe-
sis seems to be more positively influenced, relative to
type III collagen, similar to the effect seen with
TGFβ3 growth factor addition. 
These findings are encouraging when considering the
applicability of hMSCs to injured or surgically re-
paired tendon in the clinical setting, as our data may
suggest that in vivo oxygen conditions may alter the
lineage propensities of this cell type in a beneficial
manner. This being in regards to both an overall in-
crease in the rate of collagen production, but in par-
ticular, an increase in the type I:III collagen ratio. Fur-
ther study is warranted in this area to elucidate the
best efficacy and safety of this cell population as it
may be used in this setting. 
Our results may also be relevant to the field of functional
tissue engineering. Currently there are three primary
components identified for successful creation of new tis-
sues; cell source, scaffolds, and bioactive factors33. A
number of studies have shown cyclic mechanical strain
to be a potent bioactive factors for tenogenesis, demon-
strating a positive influence on MSC expression of
tenogenic markers34,35. The findings of this paper similar-
ly infer that low oxygen conditions and TGFβ3 may in
fact be crucial bioactive factors for collagen expression,
and while further study is needed, may improve biome-
chanical properties of tenogenic tissue engineered in vit-
ro for the purposes of functional tissue engineering. 
It is widely accepted that the developmental fate hMSC
progenitor cells are heavily influenced by numerous en-
vironmental factors36. However, the manner in which
these cells are influenced, and what factors they are in-
fluenced by remains a topic of study and debate. With
current technologies aiming to use these progenitor
cells in a clinical setting, it may prove beneficial for
these factors and behaviors to be more thoroughly elu-
cidated with in vitro and in vivo analysis.
Conclusion
Low oxygen and TGFβ3 demonstrated a positive ef-
fect on cell number, and type I and III collagen ex-
pression in 3D culture environments. In addition, it
was shown that both variables, together and separate
produced an increase in the type I:III collagen ratio.
The results of this study may indicate that low oxygen
culture conditions may have a significant effect on
hMSC lineage propensities which may prove to be an
important consideration for future in vitro studies. 
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